✦ LIBER ✦

Oral and intravenous pharmacokinetics of the peptidoleukotriene receptor antagonists SK&F S-106203 and 104353

✍ Scribed by J.F. Newton; L.P. Yodis; C.M. Saverino; C.O. Kenney; M. Landi; R.D. Eckardt

Book ID: 115884049
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 255 KB
Volume: 183
Category: Article
ISSN: 0014-2999
DOI: 10.1016/0014-2999(90)92208-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Preclinical and Clinical Pharmacolog

The Preclinical and Clinical Pharmacology of SK&F 104353, a Potent and Selective Peptidoleukotriene Receptor Antagonist

✍ T. J. TORPHY; I. FAIFERMAN; J. G. GLEASON; R. F. HALL; M. A. LEWIS; C. BROOM; H. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 765 KB

The effect of inhalation of the leukotri

The effect of inhalation of the leukotriene receptor antagonist, SK&F 104353, on leukotriene C- and leukotriene E-induced bronchoconstriction in subjects with asthma

✍ CHRISTIE, P; SPUR, B; LEE, T 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 664 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of L-703,014, a Potent Fibrinogen Receptor Antagonist, After Intravenous and Oral Administration in the Dog

✍ Jeffrey S. Barrett; Robert J. Gould; Joan D. Ellis; Marie M. Holahan; Maria T. S 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 893 KB

The pharmacokinetics of oral and intrave

The pharmacokinetics of oral and intravenous prenalterol in young, healthy volunteers

✍ A. F. Clarke; D. B. Jack; M. J. Kendall; S. R. Smith 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 2 views

The pharmacokinetics of prenalterol in healthy young volunteers after i.v. and oral dosing has been studied. There is evidence of non-linearity following the i.v. dosing. Evidence of dose-dependent pharmacokinetics following i.v. dosing has been obtained. The sustained-release formulation is very ef

396 POSTER Effect of oral (PO) casopitan

396 POSTER Effect of oral (PO) casopitant, a novel NK-1 receptor antagonist, on the pharmacokinetics (PK) and safety profile of intravenous (IV) docetaxel

✍ L. Adams; B. Johnson; J. Bauman; P. Lebowitz; K. Zhang; T. Webb; E. Gartner; R. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

The comparative plasma pharmacokinetics

The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs

✍ S. A. BROWN; J. F. BOUCHER; V. L. HUBBARD; M. J. PROUGH; T. F. FLOOK 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB